featured
AAN 2021: Sodium Phenylbutyrate/Taurursodiol Shows Long-Term Benefits in Amyotrophic Lateral Sclerosis
Participants in the CENTAUR trial were followed for up to 156 weeks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.